다제내성 결핵환자의 항 결핵약제 감수성 검사법에 관한 고찰

• 발행기관: 한국역학회
• 저자명: 한문덕(Mun Deok Han) 임정수(Jeong Soo Im) 임준(Jun Yim) 오대규(Dae Kyu Oh)
• 간행물 정보: 『한국역학회지』韓國疫學會誌 第30卷 第2號, 301~308쪽, 전체 8쪽
• 주제분류: 의약학 > 면역학
• 파일형태: PDF
• 발행일자: 2008.12.31

영문 초록

Multi-drug resistant tuberculosis is an emerging threat to humans. Despite steady efforts of the national tuberculosis control program, current prevalence of multi-drug resistant tuberculosis rate is increasing in Korea. In Korea, it is effective to both improve the medical transfer system on tuberculosis, and also to make a new tuberculosis patient control system with integrated public-private sector. Improvement focused on the new medical transfer system is a suitable model considering current situation of the Korean medical system. This model can be achieved by replacing the traditional drug susceptibility test method, which requires a long turnaround time, with rapid molecular biological method, and improving the overall process of specimen transport system, report system, and guidelines for tuberculosis, as well. Using such model, doctors can discover multi-drug resistant tuberculosis patients at an earlier stage, prescribe appropriate drugs at the right time, and effectively support directly observed treatment short course strategy. Therefore, this new model for improvement of multi-drug resistant tuberculosis control program, medical transfer system-focused public-private integrated system, can present an effective tool for enhancing and modifying functions of the current national tuberculosis programme in Korea.

키워드

Multi-Drug Resistant Tuberculosis Tuberculosis control program Drug susceptibility test